.
MergerLinks Header Logo

New Deal


Announced

Completed

R1 RCM completed the acquisition of Acclara from Providence for $675m.

Financials

Edit Data
Transaction Value£534m
Consideration TypeCash, Ordinary Shares
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Private

medical billing

Friendly

Domestic

revenue cycle management

United States

Health Care Services

Majority

Single Bidder

Completed

Synopsis

Edit

R1 RCM, a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, completed the acquisition of Acclara, a technology-driven revenue cycle management company, from Providence, one of the nation's largest health systems, for $675m. “We are pleased to complete the acquisition of Acclara and enter into our long-term partnership with Providence, and we look forward to the significant value we believe this transaction will create for customers and shareholders. Acclara strengthens our position as the trusted partner of choice in revenue cycle management and extends our ability to deploy advanced technology solutions and drive execution to improve customer and patient outcomes. We warmly welcome the Acclara team to R1 and look forward to new growth opportunities together and to leveraging our technology and automation capabilities across our expanded portfolio,” Lee Rivas, R1 CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US